Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Koch's dilemma revisited.

S H Kaufmann1

  • 1Max-Planck-Institute for Infection Biology, Department of Immunology, Berlin, Germany.

Scandinavian Journal of Infectious Diseases
|March 10, 2001
PubMed
Summary

Robert Koch identified the cause of tuberculosis but his claimed remedy failed in trials. However, the diagnostic use of tuberculin, derived from his work, remains valuable today.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic gene expression signature for high-grade serous ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells.

Leukemia·2016
Same author

MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.

Cell death and differentiation·2015
Same author

Bim regulation miRrors microRNA 17∼92 cluster expression in endothelial cells in vivo.

Cell death and differentiation·2014
Same author

Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.

Cell death & disease·2014
Same author

Erasable Western blots.

Methods in molecular biology (Clifton, N.J.)·2012

Area of Science:

  • Microbiology
  • Immunology
  • Medical History

Background:

  • Robert Koch identified the bacterium causing tuberculosis in 1882, becoming a prominent researcher.
  • In 1890, Koch announced a remedy for tuberculosis, generating significant public and medical anticipation.

Discussion:

  • Despite initial excitement, clinical trials demonstrated that Koch's remedy lacked therapeutic efficacy.
  • The article explores Koch's motivations for persisting with his remedy despite unfavorable trial outcomes.

Key Insights:

  • Koch's remedy for tuberculosis proved ineffective in clinical settings.
  • Tuberculin, a diagnostic tool developed by Koch, continues to be clinically relevant and valued for tuberculosis diagnosis.

Outlook:

  • Further research into Koch's historical claims and the development of tuberculosis treatments.
  • Understanding the historical context of medical discoveries and their lasting impact.

Related Experiment Videos